Access cutting-edge lupus treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access lupus specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lupus treatment provided free
This randomized, double-blind, placebo-controlled, non-inferiority crossover study will evaluate the Herpes Zoster Sunbit (HZ/su) vaccine in SLE patients in order to evaluate safety and immunogenicity in patients with variable baseline clinical activities, ages and immunosuppressant exposures. The investigators hypothesize that HZ/su administration will be non-inferior to placebo with respect to the risk of moderate or severe SLE flare(s) occurring within 24 weeks of receiving the first dose of
Sponsor: NYU Langone Health
Check if you qualify for this lupus clinical trial in New York, NY
If you're searching for lupus treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.